Matches in SemOpenAlex for { <https://semopenalex.org/work/W3060097183> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3060097183 endingPage "1358" @default.
- W3060097183 startingPage "1355" @default.
- W3060097183 abstract "Despite the overall excellent safety profile of gadolinium-based contrast agents (GBCAs) and long history of clinical use [ 1 Schieda N. Blaichman J.I. Costa A.F. et al. Gadolinium-based contrast agents in kidney disease: a comprehensive review and clinical practice guideline issued by the Canadian Association of Radiologists. Can J Kidney Health Dis. 2018; 69: 136-150 Google Scholar , 2 ACRManual on Contrast Media, version 9. http://www.acr.org/Quality-Safety/Resources/Contrast-ManualDate accessed: April 1, 2020 Google Scholar ], recent concerns have arisen because of recognition that gadolinium from GBCAs can be retained in humans for months to years after exposure. The clinical effects are unknown, and to date there is no scientific evidence linking gadolinium retention to adverse clinical outcomes. Nevertheless, a small number of patients have reported symptoms to health care regulatory bodies that they attribute to GBCA exposure and gadolinium retention. These self-reported symptoms vary in type and timing, with many occurring within 48 hours, but have not been substantiated or confirmed to be related to gadolinium retention [ 3 Costa A.F. van der Pol C.B. Maralani P.J. et al. Gadolinium deposition in the brain: a systematic review of existing guidelines and policy statement issued by the Canadian Association of Radiologists. Can Assoc Radiol J. 2018; 69: 373-382 Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar , 4 McDonald R.J. Levine D. Weinreb J. et al. Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology. 2018; 289: 517-534 Crossref PubMed Scopus (169) Google Scholar , 5 Croteau D. Adverse events with gadolinium retention after gadolinium-based contrast agent exposure: FDA Adverse Event Reporting System and medical literature review. https://www.fda.gov/media/107662/downloadDate accessed: December 8, 2019 Google Scholar ]." @default.
- W3060097183 created "2020-08-24" @default.
- W3060097183 creator A5006965802 @default.
- W3060097183 creator A5016002613 @default.
- W3060097183 creator A5021636040 @default.
- W3060097183 creator A5060220628 @default.
- W3060097183 creator A5081793276 @default.
- W3060097183 date "2020-10-01" @default.
- W3060097183 modified "2023-09-30" @default.
- W3060097183 title "Twitter and Gadolinium Retention: Patient-Reported Perceptions of Gadolinium-Based Contrast Agents" @default.
- W3060097183 cites W2156765928 @default.
- W3060097183 cites W2220563275 @default.
- W3060097183 cites W2763766763 @default.
- W3060097183 cites W2890242827 @default.
- W3060097183 cites W2891480757 @default.
- W3060097183 doi "https://doi.org/10.1016/j.jacr.2020.07.023" @default.
- W3060097183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32822645" @default.
- W3060097183 hasPublicationYear "2020" @default.
- W3060097183 type Work @default.
- W3060097183 sameAs 3060097183 @default.
- W3060097183 citedByCount "2" @default.
- W3060097183 countsByYear W30600971832021 @default.
- W3060097183 countsByYear W30600971832023 @default.
- W3060097183 crossrefType "journal-article" @default.
- W3060097183 hasAuthorship W3060097183A5006965802 @default.
- W3060097183 hasAuthorship W3060097183A5016002613 @default.
- W3060097183 hasAuthorship W3060097183A5021636040 @default.
- W3060097183 hasAuthorship W3060097183A5060220628 @default.
- W3060097183 hasAuthorship W3060097183A5081793276 @default.
- W3060097183 hasConcept C126838900 @default.
- W3060097183 hasConcept C142724271 @default.
- W3060097183 hasConcept C17744445 @default.
- W3060097183 hasConcept C191897082 @default.
- W3060097183 hasConcept C192562407 @default.
- W3060097183 hasConcept C199539241 @default.
- W3060097183 hasConcept C2779473830 @default.
- W3060097183 hasConcept C2780182762 @default.
- W3060097183 hasConcept C2989005 @default.
- W3060097183 hasConcept C557651011 @default.
- W3060097183 hasConcept C71924100 @default.
- W3060097183 hasConcept C83867959 @default.
- W3060097183 hasConceptScore W3060097183C126838900 @default.
- W3060097183 hasConceptScore W3060097183C142724271 @default.
- W3060097183 hasConceptScore W3060097183C17744445 @default.
- W3060097183 hasConceptScore W3060097183C191897082 @default.
- W3060097183 hasConceptScore W3060097183C192562407 @default.
- W3060097183 hasConceptScore W3060097183C199539241 @default.
- W3060097183 hasConceptScore W3060097183C2779473830 @default.
- W3060097183 hasConceptScore W3060097183C2780182762 @default.
- W3060097183 hasConceptScore W3060097183C2989005 @default.
- W3060097183 hasConceptScore W3060097183C557651011 @default.
- W3060097183 hasConceptScore W3060097183C71924100 @default.
- W3060097183 hasConceptScore W3060097183C83867959 @default.
- W3060097183 hasIssue "10" @default.
- W3060097183 hasLocation W30600971831 @default.
- W3060097183 hasOpenAccess W3060097183 @default.
- W3060097183 hasPrimaryLocation W30600971831 @default.
- W3060097183 hasRelatedWork W141524600 @default.
- W3060097183 hasRelatedWork W1841185769 @default.
- W3060097183 hasRelatedWork W1977039195 @default.
- W3060097183 hasRelatedWork W2049214470 @default.
- W3060097183 hasRelatedWork W2072926321 @default.
- W3060097183 hasRelatedWork W3213299891 @default.
- W3060097183 hasRelatedWork W4200106809 @default.
- W3060097183 hasRelatedWork W4231870048 @default.
- W3060097183 hasRelatedWork W4249487090 @default.
- W3060097183 hasRelatedWork W4306179204 @default.
- W3060097183 hasVolume "17" @default.
- W3060097183 isParatext "false" @default.
- W3060097183 isRetracted "false" @default.
- W3060097183 magId "3060097183" @default.
- W3060097183 workType "article" @default.